Results 161 to 169 of about 25,648 (169)

Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment

Cancer Discovery, 2019
Xufeng Chen, Christina Glytsou, Hua Zhou
exaly  

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia

Cancer Discovery, 2019
Piers A Blombery, Mary Ann Anderson, Rachel Thijssen   +2 more
exaly  

Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax

Cancer Discovery, 2017
Joan Montero, Tianyu Cai, Gabriel K Griffin   +2 more
exaly  

Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study

Lancet Oncology, The, 2016
Stephan Stilgenbauer, Johannes Schetelig, Steven Coutre   +2 more
exaly  

Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia

Nature Medicine, 2018
Daniel A Pollyea, Shanshan Pei, Angelo D'Alessandro   +2 more
exaly  

Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma

Nature Medicine, 2018
Rishu Agarwal, Yih-Chih Chan, Constantine S Tam   +2 more
exaly  

A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia

Cancer Discovery, 2018
Melissa A Fischer, Leah J Hogdal, Stephen W Fesik   +2 more
exaly  

Venetoclax in AML: efficacy confirmed

Nature Reviews Clinical Oncology, 2020
exaly  

Venetoclax–rituximab holds substantial promise in CLL

Nature Reviews Clinical Oncology, 2018
exaly